Personalised Medicine for Society

Datum: 26-01-2010 - 27-01-2010

Locatie: Brussel, Résidence Palace,

Omschrijving:

The EFGCP Annual Conference 2010
Aspects of Personalised Medicine for Society – a Challenge Yet to be Met

For the past 50 years the development of new medicines has been highly successful. As a result, many diseases
have been well treated – sometimes cured or at least their symptoms relieved. Success could be measured by the
number of patients thus treated. However, such success had to be leavened by the frequency of side effects and it
had to be recognised that potential success for an individual patient could be nullified by the unacceptability of such
side effects. So attempts were made both to increase the efficacy of new medicines and to improve their
tolerability; and, in parallel, it was realised that efficacy and tolerability of any given medicine varied between
individual patients. The traditional tools for finding the right dose for most patients were randomised controlled
clinical trials and post-marketing surveillance studies; but, recently, the recognition that the individual genetic
profiles of patients could be identified in terms of their susceptibility to treatment with medicines as well as their
susceptibility to the side effects of such medicines has enabled a paradigm shift towards the success of a new
medicine. Knowledge about the individual genome has clearly opened up huge scientific opportunities, but
accompanied by a significant need to identify, discuss and attempt to solve aspects of personalised medicine
related to society as a whole.
This conference will tackle the complex issues involved, including the ethics of providing confidential information
arising from knowledge of the individual genome, associated economic factors, access to tailor-made treatment
and how this should be prioritised. By means of a series of presentations by those experienced in handling these
issues, and six interactive workshops, the EFGCP Annual Conference 2010 will aim to identify the challenges of
personalised medicine in the context of society as a whole yet to be met. The various roles of all the stakeholders,
from the bench-based scientist to the patient, will all be discussed in the interests of identifying the best possible
treatments for the society of the future.

Meer informatie: http://www.efgcp.be

E-mailadres: conferences@efgcp.be